Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update

MJ Duffy, R Lamerz, C Haglund… - … journal of cancer, 2014 - Wiley Online Library
Biomarkers currently play an important role in the detection and management of patients
with several different types of gastrointestinal cancer, especially colorectal, gastric, gastro …

Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?

MJ Duffy - Clinical chemistry, 2001 - academic.oup.com
Background: Carcinoembryonic antigen (CEA) is one of the most widely used tumor markers
worldwide. Its main application is mostly in gastrointestinal cancers, especially in colorectal …

[HTML][HTML] Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

R Labianca, B Nordlinger, GD Beretta… - Annals of …, 2013 - annalsofoncology.org
Colorectal cancer (CRC) is the third most common tumour in men and the second in women,
accounting for 10% of all tumour types worldwide. Incidence is higher in males (ratio: 1.4) …

Effect of more vs less frequent follow-up testing on overall and colorectal cancer–specific mortality in patients with stage II or III colorectal cancer: the COLOFOL …

P Wille-Jørgensen, I Syk, K Smedh, S Laurberg… - Jama, 2018 - jamanetwork.com
Importance Intensive follow-up of patients after curative surgery for colorectal cancer is
common in clinical practice, but evidence of a survival benefit is limited. Objective To …

Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European …

V Valentini, RGPM Van Stiphout… - Journal of clinical …, 2011 - ascopubs.org
Purpose The purpose of this study was to develop accurate models and nomograms to
predict local recurrence, distant metastases, and survival for patients with locally advanced …

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer

GY Locker, S Hamilton, J Harris, JM Jessup… - Journal of clinical …, 2006 - ascopubs.org
Purpose To update the recommendations for the use of tumor marker tests in the prevention,
screening, treatment, and surveillance of gastrointestinal cancers. Methods For the 2006 …

[HTML][HTML] S3-leitlinie–kolorektales karzinom

W Schmiegel, B Buchberger… - Zeitschrift für …, 2017 - thieme-connect.com
2.1 Geltungsbereich und Zweck 2.1. 1. Zielsetzung und Fragestellung Das Kolorektale
Karzinom (KRK) ist mit etwa 64 000 Neuerkrankungen und ca. 26 000 Todesfällen pro Jahr …

Follow‐up strategies for patients treated for non‐metastatic colorectal cancer

M Jeffery, BE Hickey, PN Hider - Cochrane Database of …, 2019 - cochranelibrary.com
Follow‐up strategies for patients treated for non‐metastatic colorectal cancer - Jeffery, M - 2019
| Cochrane Library Skip to Content Cookies Our site uses cookies to improve your experience …

National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian …

CM Sturgeon, MJ Duffy, UH Stenman, H Lilja… - 2008 - academic.oup.com
Abstract Background: Updated National Academy of Clinical Biochemistry (NACB)
Laboratory Medicine Practice Guidelines for the use of tumor markers in the clinic have been …

[HTML][HTML] Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up

R Labianca, B Nordlinger, GD Beretta… - Annals of …, 2010 - annalsofoncology.org
Cancers of the colon and rectum altogether are the third most common tumour type
worldwide. Cancer of the colon is more frequent than rectal cancer: in high-risk populations …